TY - JOUR
T1 - Development of quality of life questionnaire for patients with parkinson’s disease undergoing stn-dbs
AU - Kawaguchi, Minako
AU - Miyagi, Yasushi
AU - Kishimoto, Junji
AU - Samura, Kazuhiro
AU - Tokunaga, Yutaka
AU - Watari, Mari
AU - Eguchi, Hiroko
AU - Ueda, Shintaro
AU - Iihara, Koji
N1 - Publisher Copyright:
© 2021 The Japan Neurosurgical Society.
PY - 2021
Y1 - 2021
N2 - In device-aided therapy (DAT) for Parkinson’s disease (PD), factors such as device-related adverse effects, psychological and lifestyle changes, and specific disease progression can affect the quality of life (QoL) of patients with advanced PD. However, there is no existing QoL scale that includes the effects of therapeutic devices. From a semi-structured interview with patients with PD undergoing deep brain stimulation (DBS), we extracted the content of utterances that were thought to affect the QoL and created a draft questionnaire consisting of 113 items. This questionnaire was administered to 54 other patients undergoing DBS, whose data were examined for reliability and validity by factor analysis, and finally, a 24-item PD QoL questionnaire for patients on DAT (PDQ-DAT) was developed. Presently, the PDQ-DAT is the only scale that can assess the QoL of patients on DAT, including the influence treatment devices have on them. In the future, it might be used to help in shared decision-making in medicine by incorporating the patient’s sense of burden and values in the selection of treatment methods.
AB - In device-aided therapy (DAT) for Parkinson’s disease (PD), factors such as device-related adverse effects, psychological and lifestyle changes, and specific disease progression can affect the quality of life (QoL) of patients with advanced PD. However, there is no existing QoL scale that includes the effects of therapeutic devices. From a semi-structured interview with patients with PD undergoing deep brain stimulation (DBS), we extracted the content of utterances that were thought to affect the QoL and created a draft questionnaire consisting of 113 items. This questionnaire was administered to 54 other patients undergoing DBS, whose data were examined for reliability and validity by factor analysis, and finally, a 24-item PD QoL questionnaire for patients on DAT (PDQ-DAT) was developed. Presently, the PDQ-DAT is the only scale that can assess the QoL of patients on DAT, including the influence treatment devices have on them. In the future, it might be used to help in shared decision-making in medicine by incorporating the patient’s sense of burden and values in the selection of treatment methods.
UR - http://www.scopus.com/inward/record.url?scp=85113237703&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85113237703&partnerID=8YFLogxK
U2 - 10.2176/nmc.oa.2020-0388
DO - 10.2176/nmc.oa.2020-0388
M3 - Article
C2 - 34148942
AN - SCOPUS:85113237703
SN - 0470-8105
VL - 61
SP - 475
EP - 483
JO - Neurologia Medico-Chirurgica
JF - Neurologia Medico-Chirurgica
IS - 8
ER -